1,106 material Form 8-K filings that 909 companies we cover made with the SEC in June 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Rani Therapeutics appointed Nicholas M. Maestas as Chief Financial Officer, succeeding Svai Sanford, who had previously announced he would step down once a successor was named. The company also approved a 2026 Equity Inducement Plan reserving 5,500,000 Class A shares for new-hire awards, which does not require stockholder approval.
Maestas, age 46, was CFO and Head of Corporate Strategy at Tempest Therapeutics from January 2025 until June 2026.
Offer letter dated June 24, 2026 sets an annual base salary of $500,000 and a target bonus of 75% of base salary.
Maestas will receive a non-qualified option to purchase 2,000,000 Class A shares, vesting over four years.
The Board approved the Inducement Plan on June 28, 2026, reserving 5,500,000 shares.
Four Corteva directors, Karen Grimes, Marcos Lutz, Charles Magro and Kerry Preete, agreed to resign from the Corteva board effective immediately before the planned spin-off of the seed business into Vylor, Inc. The filing says each is expected to join the Vylor board, and the resignations are not tied to any disagreement with the company. The companies also announced their post-separation boards, and the separation remains on track for the fourth quarter of 2026.
Resignations agreed June 26, 2026, and take effect only if the spin-off is completed
Greg Page to chair a nine-person Corteva board; Luke Kissam to join at separation
Karen Grimes to chair a seven-director Vylor board; a search is ongoing for at least one more member
Vylor filed its first Form 10 registration statement with the SEC; separation on track for 4Q 2026
Protara Therapeutics said its Chief Medical Officer, Leonardo Viana Nicacio, M.D., resigned to explore other opportunities, effective June 26, 2026. His duties will be taken over by Carla Beckham, M.D., and will continue under the oversight of Jacqueline Zummo, Ph.D., the company's Chief Research & Development Officer.
Leonardo Viana Nicacio, M.D., Chief Medical Officer, resigned effective June 26, 2026, to explore other opportunities
Carla Beckham, M.D., Lead Medical Director and Head of Clinical Development, will assume Dr. Nicacio's duties
Jacqueline Zummo, Ph.D., Chief Research & Development Officer, will oversee the work
TransAct Technologies appointed Troy W. Ingianni, formerly Vice President, Global Controller and Chief Accounting Officer at Barnes Group, as Chief Financial Officer, Secretary and Treasurer effective July 1, 2026, replacing Steven DeMartino, who retires from those roles June 30, 2026. The Board's earlier choice of Controller Robert Campbell for the role was withdrawn for personal reasons, and Mr. Ingianni also takes over as Principal Accounting Officer.
Ingianni's offer letter sets a base salary of $350,000 (prorated for 2026) and a target bonus of 35% of base salary.
He will receive 15,000 restricted stock units vesting in four equal annual installments.
Severance is six months' base salary for termination without cause, or 12 months' base salary following a change in control.
John M. Dillon, CEO, will also take the title of President upon DeMartino's retirement.
ITT Inc. said its board elected two new independent directors, Bertrand Loy and Kevin Wheeler, effective August 1, 2026, and increased the board from ten to twelve members. The filing describes both men as former chief executives of industrial and technology manufacturers, which the company says will add relevant expertise to the board.
Bertrand Loy is Executive Chairman and former CEO of Entegris, Inc.; he joins the Audit Committee effective August 1, 2026.
Kevin Wheeler is Executive Chairman and former CEO of A. O. Smith Corporation; he joins the Nominating and Governance Committee effective August 1, 2026.
The board increased its size from ten to twelve directors, effective August 1, 2026.
The board determined both directors are independent under NYSE listing standards.
Synchrony Financial announced executive leadership changes effective June 29, 2026. Carol Juel, formerly Executive Vice President, Chief Technology and Operating Officer, becomes Executive Vice President and Chief Executive Officer of the Digital platform, succeeding Bart Schaller, who plans to retire after a 35-year career. The company also promoted Florin Arghirescu to Chief Technology Officer and expanded DJ Casto's role to include Operations.
Carol Juel named EVP and CEO of the Digital platform, succeeding Bart Schaller, effective June 29, 2026
Florin Arghirescu promoted to EVP and Chief Technology Officer, reporting to CEO Brian Doubles
DJ Casto appointed EVP, Chief People and Operations Officer, adding servicing, collections and customer care to Human Resources
Frontdoor, Inc. elected Hilla Sferruzza, Executive Vice President and Chief Financial Officer of Meritage Homes, as a director on June 29, 2026, effective immediately, and appointed her to the Audit Committee. The company's press release says the board was expanded to nine members to make the appointment. The filing states the board has determined she is independent under Nasdaq standards.
Director elected and Audit Committee appointment effective June 29, 2026
Standard non-employee director pay is $90,000 per year in cash, plus $180,000 per year in fully vested shares, with an added $12,500 per year in cash for Audit Committee service
Board expanded to nine members; Sferruzza will stand for re-election at the 2027 annual meeting
Seaport Entertainment Group's executive vice president, general counsel and corporate secretary, Lucy Fato, left that role effective June 25, 2026, in a termination without cause. She will serve as an advisor to the CEO and remain employed through August 24, 2026. Her separation payments are subject to a release and to her providing the agreed services through that date; the filing does not state payment amounts.
Effective June 25, 2026, Lucy Fato ceased to serve as EVP, General Counsel and Corporate Secretary
Fato will be an advisor to CEO Matthew M. Partridge's office through the Separation Date of August 24, 2026
Separation is a termination without cause under her employment agreement, with payments subject to a release and continued services
Terms are set out in a Letter Agreement dated June 25, 2026, filed as Exhibit 10.1
Pinnacle West's Human Resources Committee approved a $1.5 million discretionary credit award for Adam Heflin, executive vice president and chief nuclear officer of Arizona Public Service. The credits are tied to his continued employment and vest on May 1, 2030, which is a retention arrangement rather than a change in leadership.
Total discretionary credits of $1.5 million, paid in installments of $300,000 on July 1, 2026 and July 1, 2027, $400,000 on July 1, 2028, and $500,000 on July 1, 2029
Account vests May 1, 2030 if Heflin remains employed with APS through that date
Unvested amounts are forfeited if he separates from service, except on death, disability or termination without cause
Copart's board appointed Executive Chairman A. Jayson Adair as chief executive effective July 31, 2026, replacing Jeffrey Liaw, who will also resign from the board. The filing discloses a transition agreement for Liaw with a $450,000 lump sum, $200,000 paid during a transition period through July 31, 2027, and additional conditional severance and equity benefits, which shareholders may weigh as part of the leadership change.
Adair, who previously led Copart as CEO, takes over on July 31, 2026, and Liaw steps down as CEO and director on the same date.
Liaw's transition agreement provides a $450,000 lump sum and $200,000 during the transition period, subject to a general release.
Liaw's conditional severance includes $250,000, accelerated vesting of remaining equity awards, and an extension of stock option exercise periods.
Adair is the son-in-law of Chairman Wills J. Johnson, a relationship the filing says is disclosed in the 2025 proxy statement.
Fortune Brands Innovations appointed Jesse Singh, former CEO of The AZEK Company, as chief executive and a board member, effective June 29, 2026. Interim CEO David Barry was named Executive Vice President and Chief Operating Officer, and the company has begun a strategic review of its Fiberon business.
Singh's base salary is $1,100,000, with a bonus target of 150% of salary and an annual long-term incentive target of $6,700,000.
Singh's inducement awards, granted July 1, 2026, cover 850,000 performance-based RSUs and a 300,000-share stock option award.
Barry receives a performance-based RSU award with a target grant value of $1,200,000 and a 25,000-share option award as COO.
Interim CFO Ashley George will remain in her role while the search for a permanent CFO continues.
Genesco said Jonathan Collins will become Senior Vice President, Finance and Chief Financial Officer on August 3, 2026, and serve as principal financial officer from that date. Board Chair, President and CEO Mimi E. Vaughn, who has been interim CFO since March 2026, will stop serving in that role on the same date. The filing sets out Collins' pay package, which includes a $550,000 base salary and a $1,787,500 initial total direct compensation at target.
Collins' annual base salary is $550,000, with a Fiscal 2027 short-term incentive target of $412,500 and a long-term incentive target of $825,000.
Collins previously served as CFO of America's Car-Mart, Inc. from May 2025, and spent 2012 to 2025 at Walmart Inc., including as CFO of Walmart Africa.
Vaughn, who served as interim CFO since March 2026, will no longer be interim CFO or principal financial officer as of August 3, 2026.
Collins will receive a $25,000 quarterly relocation stipend, payable for three quarters.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.